NDC Package 47426-201-01 Cinvanti

Aprepitant Injection, Emulsion Intravenous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
47426-201-01
Package Description:
1 VIAL, GLASS in 1 CARTON / 18 mL in 1 VIAL, GLASS
Product Code:
Proprietary Name:
Cinvanti
Non-Proprietary Name:
Aprepitant
Substance Name:
Aprepitant
Usage Information:
Aprepitant is used with other medications to help prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). It works by blocking one of the body's natural substances (substance P/neurokinin 1) that causes vomiting.
11-Digit NDC Billing Format:
47426020101
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1995150 - aprepitant 130 MG in 18 ML Injection
  • RxCUI: 1995150 - 18 ML aprepitant 7.2 MG/ML Injection
  • RxCUI: 1995150 - aprepitant 130 MG per 18 ML Injection
  • RxCUI: 1995155 - CINVANTI 130 MG in 18 ML Injection
  • RxCUI: 1995155 - 18 ML aprepitant 7.2 MG/ML Injection [Cinvanti]
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Heron Therapeutics, Inc.
    Dosage Form:
    Injection, Emulsion - An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    NDA209296
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    01-03-2018
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 47426-201-01?

    The NDC Packaged Code 47426-201-01 is assigned to a package of 1 vial, glass in 1 carton / 18 ml in 1 vial, glass of Cinvanti, a human prescription drug labeled by Heron Therapeutics, Inc.. The product's dosage form is injection, emulsion and is administered via intravenous form.

    Is NDC 47426-201 included in the NDC Directory?

    Yes, Cinvanti with product code 47426-201 is active and included in the NDC Directory. The product was first marketed by Heron Therapeutics, Inc. on January 03, 2018 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 47426-201-01?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 47426-201-01?

    The 11-digit format is 47426020101. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-247426-201-015-4-247426-0201-01